Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes
Nature Communications2014Vol. 5(1), pp. 5893–5893
Citations Over TimeTop 10% of 2014 papers
Saravana M. Dhanasekaran, O. Alejandro Balbin, Guoan Chen, Ernest Nadal, Shanker Kalyana‐Sundaram, Jincheng Pan, Brendan Veeneman, Xuhong Cao, Rohit Malik, Pankaj Vats, Rui Wang, Stephanie Huang, Jinjie Zhong, Xiaojun Jing, Matthew K. Iyer, Yi-Mi Wu, Paul W. Harms, Jules Lin, Rishindra M. Reddy, Christine Brennan, Nallasivam Palanisamy, Andrew C. Chang, Anna Truini, Mauro Truini, Dan R. Robinson, David G. Beer, Arul M. Chinnaiyan
Related Papers
- The potential and limitation of targeted chromosomal breakpoint sequencing for the ROS1 fusion gene identification in lung cancer.(2022)
- [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation].(2015)
- → [Clinical utility of real-time fluorescent PCR for combined detection of anaplastic lymphoma kinase and c-ros oncogene 1 receptor tyrosine kinase in non-small cell lung cancer].(2016)1 cited
- → The landscape of kinase fusions in 445 Chinese NSCLC patients(2017)1 cited
- 非小细胞肺癌组织中 ALK、ROS1和 RET融合基因的表达及其临床意义(2015)